Clin2
NCT06774846Possibly a fitNot yet recruiting

Aspirin for pneumonia in older adults

Acute PneumoniaElderly Person

Part of Infections, Lungs & breathing clinical trials.

This trial tests whether a daily low dose of aspirin can help older adults recover from pneumonia. It aims to reduce inflammation and improve outcomes for patients hospitalized with the infection.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
600 people
Ages
75 years and older
Study type
Interventional

Who can take part

  • You are 75 years old or older.
  • You have been diagnosed with pneumonia and are currently in the hospital.
  • You have at least two of these symptoms: cough, coughing up mucus, chest pain, shortness of breath or fast breathing, fever or low temperature, or crackling sounds in your lungs.
  • Your pneumonia symptoms started less than 7 days ago.
  • You are not currently taking blood thinners (like warfarin or heparin) or antiplatelet drugs (like clopidogrel or ticagrelor).
  • You do not have a history of bleeding problems or stomach ulcers.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06092008Recruiting
New pneumonia tests for adults 65 and older

This study tests new ways to diagnose pneumonia faster and more accurately in older adults who come to the emergency room with breathing problems. The goal is to see if these new tests work better than the current methods.

Columbus, Ohio
NCT05452941Recruiting
Pneumonia vaccine study for hospitalized adults 65 and older

This study tests a pneumococcal vaccine designed for 20 types of bacteria in older adults who are hospitalized with suspected community-acquired pneumonia. It aims to see how the vaccine works in real-world care and whether it affects how pneumonia happens or progresses.

El Centro, California
NCT05265299Recruiting· Phase 3
Testing the right aspirin dose for COPD symptoms

This Phase 3 trial studies which aspirin dose works best in people with COPD, with the goal of improving disease control. You may be asked to take aspirin and be monitored for safety, especially bleeding risk and heart/brain history.

Baltimore, Maryland
NCT06998251Recruiting
Immune response to strep pneumonia in older adults

This study looks at how the immune system in the nose and throat reacts to Streptococcus pneumoniae bacteria and viruses in adults aged 60-85. It may help researchers find better ways to prevent or treat pneumonia.

Geneva
NCT07070284Enrolling by invitation
Severe pneumonia in older adults: a study of risks and outcomes

This study looks at older adults with severe pneumonia to understand what causes it and how to improve outcomes. If you are 65 or older and have severe pneumonia, this trial may help doctors learn more about your condition.

Zagreb, City of Zagreb
NCT06295120Recruiting· Phase 4
Finding the best antibiotic course for pneumonia in adults

This trial is testing how many days of antibiotics are best for adults with pneumonia who are treated by their regular doctor (not in a hospital). The goal is to find the shortest effective treatment to reduce side effects and antibiotic resistance.

Gistrup

Hear when a new Elderly Person trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.